Atossa Genetics Inc (ATOS NASDAQ) stock market data APIs
$2.52
-0(-0%)
as of September 4, 2026
Try our APIs with
free plan!
Atossa Genetics Inc Financial Data Overview
Price chart is built with
Anychart
Atossa Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops medicines in areas of significant unmet medical need in oncology in the United States. Its lead drug candidate is oral (Z)-endoxifen, a selective estrogen receptor modulator and selective estrogen receptor degrader currently in Phase 2 clinical development for the treatment and reduction of risk of breast cancer, as well as in other therapeutic areas. The company was formerly known as Atossa Genetics Inc. and changed its name to Atossa Therapeutics, Inc. in January 2020. Atossa Therapeutics, Inc. was founded in 2008 and is based in Seattle, Washington.
Prev. Close
2.52
Open
2.5191
High
2.5961
Low
2.5053
52 wk Range
1.7-19.35
Market Cap
25 148 K
Shares Outstanding
9 979 K
EPS
-0.95
Beta
1.275
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
ETFs with Atossa Genetics Inc (top by weight)
Ticker
100-day Price Change
Weight
* We provide detailed information about ETF constituents through our Fundamentals API for ETFs. Read the documentation to learn more.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Atossa Genetics Inc data using free add-ons & libraries
Get Atossa Genetics Inc Fundamental Data
Atossa Genetics Inc Fundamental data includes:
- Net Revenue:
- EBITDA: -39 235 000
- Earnings Per Share: -4
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2026-08-07
- EPS/Forecast: -1.04
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Atossa Genetics Inc News
New
Straight Out Of A Soap Opera: Biotech Exec Arrested After 21 Years On The Run
One of Rhode Island's most-wanted fugitives was captured Monday after apparently hiding out for 20 years as a biotech executive. Continue Reading
Top Midday Decliners
Oracle (ORCL) plans to raise about $40 billion via debt and equity issuances in fiscal 2027, includi PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscri...
Atossa Therapeutics Announces $16.5 Million Registered Direct Offering; Stock Down
(RTTNews) - Atossa Therapeutics, Inc. (ATOS) has entered into a securities purchase agreement with institutional investors for a registered direct offering of up to $16.5 million in gross proceeds. Th...
Atossa Therapeutics prices up to $16.5M direct offering
* Atossa Therapeutics (ATOS [https://seekingalpha.com/symbol/ATOS]) said [https://seekingalpha.com/pr/20548351-atossa-therapeutics-announces-registered-direct-offering-of-up-to-16_5-million-in-gross...
Get Atossa Genetics Inc fresh news feed via Financial News API
Corporate Events Calendar & News package for
$19.99/mo.
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
Best Offer
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
